| Functional interaction between opioid and cannabinoid receptors in drug self-administration M Navarro, MRA Carrera, W Fratta, O Valverde, G Cossu, L Fattore, ... Journal of Neuroscience 21 (14), 5344-5350, 2001 | 430 | 2001 |
| Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat M Navarro, E Hernández, RM Muñoz, I del Arco, MA Villanúa, ... Neuroreport 8 (2), 491-496, 1997 | 375 | 1997 |
| Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function D Cota, MA Steiner, G Marsicano, C Cervino, JP Herman, Y Grubler, ... Endocrinology 148 (4), 1574-1581, 2007 | 247 | 2007 |
| Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats M Granado, T Priego, AI Martín, MA Villanúa, A López-Calderón American Journal of Physiology-Endocrinology and Metabolism 288 (3), E486-E492, 2005 | 247 | 2005 |
| The effect of melatonin on in vitro fertilization and embryo development in mice B Ishizuka, Y Kuribayashi, K Murai, A Amemiya, MT Itoh Journal of pineal research 28 (1), 48-51, 2000 | 211 | 2000 |
| Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion LL Murphy, RM Muñoz, BA Adrian, MA Villanúa Neurobiology of disease 5 (6), 432-446, 1998 | 199 | 1998 |
| CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats M Navarro, J Chowen, MRA Carrera, I del Arco, MA Villanúa, Y Martin, ... Neuroreport 9 (15), 3397-3402, 1998 | 193 | 1998 |
| Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and … JJ FemándeZ-Ruiz, RM Muñoz, J Romero, MA Villanua, A Makriyannis, ... Biochemical pharmacology 53 (12), 1919-1927, 1997 | 111 | 1997 |
| Characterization of the acute endocrine actions of (−)-11-hydroxy-Δ8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats JL Martı́n-Calderón, RM Muñoz, MA Villanúa, I del Arco, JL Moreno, ... European journal of pharmacology 344 (1), 77-86, 1998 | 75 | 1998 |
| Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation M Granado, AI Martín, MÁ Villanúa, A López-Calderón American Journal of Physiology-Endocrinology and Metabolism 292 (6), E1656-E1665, 2007 | 73 | 2007 |
| Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle M Granado, T Priego, AI Martín, MÁ Villanúa, A López-Calderón American Journal of Physiology-Endocrinology and Metabolism 289 (6), E1007-E1014, 2005 | 73 | 2005 |
| GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia M Granado, AI Martin, M Lopez-Menduina, A López-Calderón, ... American Journal of Physiology-Endocrinology and Metabolism 294 (1), E131-E141, 2008 | 70 | 2008 |
| Circadian rhythms in airline pilots submitted to long-haul transmeridian flights C Ariznavarreta, DP Cardinali, MA Villanua, B Granados, M Martin, ... Aviation, Space and Environmental Medicine 73 (5), 445-455, 2002 | 68 | 2002 |
| Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors E Castillero, AI Martín, M Lopez-Menduina, MA Villanúa, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2009 | 67 | 2009 |
| Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide S González, J Romero, R De Miguel, I Lastres-Becker, MA Villanua, ... Life sciences 65 (3), 327-336, 1999 | 67 | 1999 |
| IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting E Castillero, AI Martín, M López-Menduiña, M Granado, MÁ Villanúa, ... Molecular and cellular endocrinology 309 (1-2), 8-16, 2009 | 65 | 2009 |
| Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3 JL Chicharro, A López-Calderon, J Hoyos, AI Martin-Velasco, G Villa, ... British journal of sports medicine 35 (5), 303-307, 2001 | 65 | 2001 |
| Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs R de Miguel, J Romero, RM Muñoz, L Garcı́a-Gil, S González, ... Biochemical pharmacology 56 (10), 1331-1338, 1998 | 65 | 1998 |
| Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy E Castillero, MP Nieto-Bona, C Fernández-Galaz, AI Martín, ... American Journal of Physiology-Endocrinology and Metabolism 300 (5), E790-E799, 2011 | 63 | 2011 |
| Maternal exposure to low doses of Δ9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring P Rubio, FR De Fonseca, JL Martı́n-Calderón, I Del Arco, S Bartolomé, ... Pharmacology Biochemistry and Behavior 61 (3), 229-238, 1998 | 61 | 1998 |
